Abstract

Visceral leishmaniasis (VL) is one of the leading infectious diseases affecting developing countries. Colloidal gold-based diagnostic tests are rapid tools to detect blood/serum antibodies for VL diagnosis. Lack of uniformity in the performance of these tests in different endemic regions is a hurdle in early disease diagnosis. This study is designed to validate a serum-based dipstick test in eight centres of six countries, India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain with archived and fresh sera from 1003 subjects. The dipstick detects antibodies against Leishmania donovani membrane antigens (LAg). The overall sensitivity and specificity of the test with 95% confidence intervals were found to be 97.10% and 93.44%, respectively. The test showed good sensitivity and specificity in the Indian subcontinent (>95%). In Brazil, Ethiopia, and Spain the sensitivity and specificity of the dipstick test (83.78–100% and 79.06–100%) were better as compared to the earlier reports of the performance of rK39 rapid test in these regions. Interestingly, less cross-reactivity was found with the cutaneous form of the disease in Spain, Brazil, and Sri Lanka demonstrating 91.58% specificity. This dipstick test can therefore be a useful tool for diagnosing VL from other symptomatically similar diseases and against cutaneous form of leishmaniasis.

Details

Title
A multicentric evaluation of dipstick test for serodiagnosis of visceral leishmaniasis in India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain
Author
Ejazi Sarfaraz Ahmad 1 ; Ghosh Sneha 1 ; Saha Samiran 2 ; Choudhury Somsubhra Thakur 1 ; Bhattacharyya Anirban 1 ; Chatterjee Mitali 3 ; Pandey, Krishna 4 ; Das, V N, R 4 ; Das, Pradeep 4 ; Rahaman Mehebubar 5 ; Goswami, Rama Prosad 5 ; Rai Keshav 6 ; Khanal Basudha 6 ; Bhattarai, Narayan Raj 6 ; Bhagya, Deepachandi 7 ; Siriwardana, Yamuna Deepani 7 ; Karunaweera Nadira D 7 ; deBrito Maria Edileuza Felinto 8 ; Gomes Yara de Miranda 8 ; Nakazawa Mineo 8 ; Costa Carlos Henrique Nery 9 ; Emebet, Adem 10 ; Arega, Yeshanew 10 ; Roma, Melkamu 10 ; Fikre Helina 10 ; Hurissa Zewdu 10 ; Diro Ermias 10 ; Carrillo, Eugenia 11 ; Moreno, Javier 11   VIAFID ORCID Logo  ; Ali, Nahid 1 

 CSIR-Indian Institute of Chemical Biology, Kolkata, India (GRID:grid.417635.2) (ISNI:0000 0001 2216 5074) 
 Visva-Bharati, Department of Biotechnology, Santiniketan, India (GRID:grid.440987.6) (ISNI:0000 0001 2259 7889) 
 Institute of Postgraduate Medical Education and Research, Kolkata, India (GRID:grid.414764.4) (ISNI:0000 0004 0507 4308) 
 Rajendra Memorial Research Institute of Medical Sciences, Patna, India (GRID:grid.203448.9) (ISNI:0000 0001 0087 4291) 
 School of Tropical Medicine, Kolkata, India (GRID:grid.418546.a) (ISNI:0000 0004 1799 577X) 
 B. P. Koirala Institute of Health Sciences, Dharan, Nepal (GRID:grid.414128.a) (ISNI:0000 0004 1794 1501) 
 University of Colombo, Faculty of Medicine, Colombo, Sri Lanka (GRID:grid.8065.b) (ISNI:0000000121828067) 
 Aggeu Magalhhaes Institute, Oswaldo Cruz Foundation, Recife, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931) 
 Universidade Federal do Piaui, Teresina, Brazil (GRID:grid.412380.c) (ISNI:0000 0001 2176 3398) 
10  University of Gondar, Gondar, Ethiopia (GRID:grid.59547.3a) (ISNI:0000 0000 8539 4635) 
11  Instituto de Salud Carlos III, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2488175655
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.